Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 12-2023 | 09-2023 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,938,739 | 1,727,050 | 2,304,552 | 4,098,855 | 2,710,894 |
| Marketable Securities | 228,589 | 213,914 | 204,626 | 301,680 | 223,508 |
| Receivables | 3,840,019 | 3,440,154 | 3,481,761 | 3,483,662 | 3,286,909 |
| Inventories | 1,638,688 | 1,536,664 | 1,474,171 | 1,461,635 | 1,158,869 |
| Other current assets | 294,215 | 222,911 | 240,506 | 271,582 | 235,230 |
| TOTAL | $7,940,250 | $7,140,693 | $7,705,616 | $9,617,414 | $7,615,410 |
| Non-Current Assets | |||||
| PPE Net | 1,981,990 | 1,965,397 | 2,046,229 | 2,122,723 | 1,910,653 |
| Investments And Advances | 850,547 | 797,014 | 818,595 | 806,614 | 729,191 |
| Intangibles | 12,459,719 | 12,514,108 | 13,360,972 | 6,906,581 | 6,678,303 |
| Other Non-Current Assets | 674,774 | 489,821 | 515,424 | 971,753 | 915,463 |
| TOTAL | $15,967,030 | $15,766,340 | $16,741,220 | $10,807,670 | $10,233,610 |
| Total Assets | $23,907,290 | $22,907,040 | $24,446,850 | $20,425,090 | $17,849,030 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,517,414 | 2,768,804 | 2,874,250 | 2,255,700 | N/A |
| Accounts payable and accrued liabilities | 1,108,134 | 1,022,897 | 1,016,025 | 1,010,605 | 953,069 |
| Other current liabilities | 3,309,709 | 3,132,372 | 3,232,126 | 3,123,020 | 2,646,944 |
| TOTAL | $8,792,391 | $7,845,262 | $8,019,587 | $7,237,906 | $5,011,925 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,835,590 | 3,153,867 | 3,264,073 | 365,000 | N/A |
| Other Non-Current Liabilities | 1,261,658 | 1,209,693 | 1,212,260 | 1,252,015 | 588,221 |
| TOTAL | $4,385,683 | $4,839,648 | $5,115,777 | $1,664,750 | $1,687,095 |
| Total Liabilities | $13,178,070 | $12,684,900 | $13,135,360 | $8,902,649 | $6,699,021 |
| Shareholders' Equity | |||||
| Common Shares | 659,206 | 700,407 | 710,707 | 751,907 | 731,307 |
| Retained earnings | 5,016,173 | 5,702,623 | 6,103,146 | 6,457,098 | 7,073,347 |
| Other shareholders' equity | 4,132,256 | 2,806,816 | 3,477,806 | 3,246,763 | 2,226,160 |
| TOTAL | $10,729,230 | $10,222,130 | $11,311,480 | $11,522,440 | $11,150,010 |
| Total Liabilities And Equity | $23,907,300 | $22,907,030 | $24,446,840 | $20,425,089 | $17,849,031 |